Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 50, 2012, Pages

  Tsang, Chi Man ^a   Yip, Yim Ling ^a   Lo, Kwok Wai ^b   Deng, Wen ^a   To, Ka Fai ^b   Hau, Pok Man ^a   Lau, Victoria Ming Yi ^a   Takada, Kenzo ^c   Lui, Vivian Wai Yan ^d   Lung, Maria Li ^a   Chen, Honglin ^a   Zeng, Musheng ^e   Middeldorp, Jaap Michiel ^f   Cheung, Annie Lai Man ^a   Tsao, Sai Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e SUN YAT SEN UNIVERSITY   (China)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

episome; Epstein Barr virus; Viral persistence

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P16; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL POPULATION; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; GENE OVEREXPRESSION; IN VITRO STUDY; NASOPHARYNGEAL EPITHELIAL CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE;

BASE SEQUENCE; CELL AGING; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CYCLIN D1; DNA, VIRAL; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION; GENES, BCL-1; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION; TELOMERASE;

HUMAN HERPESVIRUS 4;

EID: 84870931320     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202637109     Document Type: Article

References (36)

1. Niedobitek G, Agathanggelou A, Nicholls JM (1996) Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: Viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Seminars in Cancer Biology 7(4):165-174. (Pubitemid 26395118)
2. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12(6):431-441.
3. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4(10):757-768. (Pubitemid 39331148)
4. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333(11):693-698.
5. Lo KW, Chung GT, To KF (2012) Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 22(2):79-86.
6. Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5(5):423-428. (Pubitemid 38612865)
7. Tsao SW, et al. (2012) The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22(2):137-143.
8. Tsang CM, et al. (2010) Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization. Int J Cancer 127(7):1570-1583.
9. Lo KW, Huang DP, Lau KM (1995) p16 gene alterations in nasopharyngeal carcinoma. Cancer Res 55(10):2039-2043.
10. Hui AB, et al. (2005) Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 65(18):8125-8133. (Pubitemid 41330575)
11. Nishi K, Inoue H, Schnier JB, Rice RH (2009) Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchoragedeprivation in human keratinocytes. J Cell Biochem 106(1):63-72.
12. Müller H, et al. (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91(8):2945-2949. (Pubitemid 24130151)
13. Latella L, et al. (2001) Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol Cell Biol 21(16):5631-5643. (Pubitemid 32702466)
14. Li QX, et al. (1992) Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356(6367):347-350.
15. Walling DM, Flaitz CM, Nichols CM, Hudnall SD, Adler-Storthz K (2001) Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J Infect Dis 184(12):1499-1507. (Pubitemid 33139734)
16. Yoo L, Speck SH (2000) Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wildtype viruses recovered from cottontop marmoset lymphoblastoid cell lines. J Virol 74 (23):11115-11120. (Pubitemid 32223977)
17. Perdiguero B, Esteban M (2009) The interferon system and vaccinia virus evasion mechanisms. Journal of Interferon and Cytokine Research 29(9):581-598.
18. Covarrubias S, Richner JM, Clyde K, Lee YJ, Glaunsinger BA (2009) Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J Virol 83(18):9554-9566.
19. Rowe M, et al. (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci USA 104(9):3366-3371. (Pubitemid 46364165)
20. Chen CJ, Makino S (2004) Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J Virol 78(11):5658-5669.
21. He Y, et al. (2010) Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol 84(24):12832-12840.
22. Liu M, et al. (2008) Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle. J Virol 82(17):8442-8455.
23. Cayrol C, Flemington EK (1996) The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15(11):2748-2759.
24. Chen YL, et al. (2009) The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. Cell Cycle 8(1):58-65.
25. Li HM, et al. (2006) Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 119(7):1567-1576. (Pubitemid 44258762)
26. Lo KW, Huang DP (2002) Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12(6):451-462.
27. Nanbo A, Sugden A, Sugden B (2007) The coupling of synthesis and partitioning of EBV' s plasmid replicon is revealed in live cells. EMBO J 26(19):4252-4262. (Pubitemid 47525164)
28. Nanbo A, Yoshiyama H, Takada K (2005) Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J Virol 79(19):12280-12285. (Pubitemid 41346089)
29. Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79(2):1296-1307. (Pubitemid 40053911)
30. MacCallum P, Karimi L, Nicholson LJ (1999) Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells. J Gen Virol 80(Pt 6):1501-1512. (Pubitemid 29261482)
31. Herrmann K, Frangou P, Middeldorp J, Niedobitek G (2002) Epstein-Barr virus replication in tongue epithelial cells. J Gen Virol 83(Pt 12):2995-2998. (Pubitemid 36054344)
32. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP (2002) The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 12(6):473-487. (Pubitemid 35370760)
33. Dawson CW, Port RJ, Young LS (2012) The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 22(2):144-153.
34. Klein E, Kis LL, Klein G (2007) Epstein-Barr virus infection in humans: From harmless to life endangering virus-lymphocyte interactions. Oncogene 26(9):1297-1305. (Pubitemid 46328467)
35. Maruo S, et al. (2011) Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci USA 108(5):1919-1924.
36. Shannon-Lowe C, et al. (2009) Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: Viral genome expression, genome maintenance, and genome amplification. J Virol 83(15):7749-7760.